In this KDIGO Guideline Education Meeting (GEM) recording, Dr. Ian de Boer (USA) presents "CKD Care in Persons with Diabetes: From Prevention to Optimal Management," highlighting key updates from the KDIGO 2026 Diabetes and CKD Guideline, highlighting a shift toward more personalized, prevention-focused care while maintaining core therapies like lifestyle changes, RAS inhibitors, and SGLT2 inhibitors, alongside expanded recommendations for GLP-1 receptor agonists and finerenone.

The presentation was part of the KDIGO GEM: From Kidney Disease Prevention to Averting Progression and Complications, held in collaboration with the Tokushukai Medical Group during the 2026 World Congress of Nephrology in Yokohama, Japan. The symposium focused on translating the latest KDIGO Guidelines into practical, patient-centered care.

For more information, please visit: https://kdigo.org/events/kdigo-guidel...